Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

MK-386 lowers DHT in blood and skin but not in semen.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

5α-Reductase inhibitors can negatively impact sexual function.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride is made through a series of chemical reactions starting from a specific intermediate compound.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

New compounds show promise as nonsteroidal treatments for hair loss.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

New compounds may help treat prostate issues without affecting androgen receptors.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.